Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWUlifoxacin is a fluoroquinolone antibiotic and an active metabolite of prulifloxacin (Item No. 31624).1 It is active against 29 clinical bacterial isolates, including L. monocytogenes, oxacillin-resistant and -suseptible S. aureus, and E. coli (MIC50s = <0.015-32 µg/ml).
WARNING This product is not for human or veterinary use.
1. In vitro antibacterial activities of AF 3013, the active metabolite of prulifloxacin, against nosocomial and community Italian isolates. Antimicrob. Agents Chemother. 45(12), 3616-3622 (2001).